InsidersTradesSigma
EQL Pharma AB: management transactions · Finland · FIN-FSA
FI:eql-pharma-abSE0005497732FI·FIN-FSAMcap 772M€Healthcare
Browse the full directors' dealings record of EQL Pharma AB, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, EQL Pharma AB has recorded 3 reports. Market capitalisation: €772.2m. The latest transaction was disclosed on 30 December 2025 — Purchase. Among the most active insiders: Martin Kristofferson. Every trade is accessible without an account.
3
Insider Decl.
0
Thresholds
€238,161
3 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
26.15 €
Analyst consensus
1 analystsStrong buy
50.00 €Target 50.00 €(+91%)50.00 €
Income statement
Revenue373.5 M€
Gross profit156.0 M€42% margin
Net income43.1 M€-1.9% margin
Valuation
PER (trailing)62.3x
PER (forward)10.6x
P/Book2.9x
Balance sheet & cash
Market cap772.2 M€
Total debt455.7 M€
Free Cash Flow−270.5 M€
Profitability & ownership
ROE-1.1%
ROA-0.6%
% insiders61.1%
% institutions16.1%
Last declaration on 30 December 2025
Declarations0 total
No declarations found
0 of 0 declarations